Explainer

Explainer: How come some AstraZeneca vaccine recipients develop blood clots

Andrew Brown
Updated April 15 2021 - 3:13pm, first published 4:00am
Advice was changed for the AstraZeneca vaccine in Australia due to the blood-clotting risk. Picture: Karleen Minney
Advice was changed for the AstraZeneca vaccine in Australia due to the blood-clotting risk. Picture: Karleen Minney

The small risk of patients developing a rare blood-clotting condition after receiving a dose of the AstraZeneca vaccine has led to a major roadblock and delay for Australia's rollout of the COVID jab.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
Andrew Brown

Andrew Brown

Journalist

I've been part of the Canberra Times since 2016, after reporting at local papers in Sydney's north-west. Since starting at the paper I've had stints on the Sunday Times, on the early morning breaking news round, and now as a general reporter, covering the ins and outs of anything and everything happening in Canberra, with a focus on health.